Stay updated on Emricasan for Decompensated NASH Cirrhosis Clinical Trial
Sign up to get notified when there's something new on the Emricasan for Decompensated NASH Cirrhosis Clinical Trial page.

Latest updates to the Emricasan for Decompensated NASH Cirrhosis Clinical Trial page
- CheckyesterdayChange DetectedA new Locations section was added, listing study sites by state (Arizona, California, Colorado, Connecticut, Florida, Georgia, Illinois, Indiana, Iowa, Louisiana, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, New Jersey, New York, North Carolina, Ohio, Oklahoma, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Virginia, Washington). The previous per-state location blocks were removed.SummaryDifference2%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedRevision: v3.3.2; no substantive changes to study details, eligibility criteria, locations, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check30 days agoChange DetectedPublication notes were updated to indicate PubMed entries are auto-filled and the revision tag updated to v3.3.1 (removing the older wording tied to v3.2.0).SummaryDifference0.1%

- Check38 days agoChange DetectedRemoved the government funding operating status notice from the page, which previously warned about updates due to funding lapses. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check52 days agoChange DetectedNo additions or deletions were observed between the two screenshots. The page content appears unchanged.SummaryDifference0.3%

- Check80 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference3%

Stay in the know with updates to Emricasan for Decompensated NASH Cirrhosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Emricasan for Decompensated NASH Cirrhosis Clinical Trial page.